Medical Program: FDA-Approved Gene Therapy Could Reverse Blindness in Children & Adults

Be part of the knowledge.

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

FDA-Approved Gene Therapy Reverses Blindness in Children & Adults

The FDA recently approved the first worldwide treatment for inherited blindness. Join us as we discuss this groundbreaking discovery.
  • Sponsored by

  • Overview

    Power couple Drs. Jean Bennett and Albert Maguire discuss how their new therapy for the RPE65 gene, which causes retinal blindness, was recently approved by the FDA to become the first gene therapy treatment for a genetic disease in the United States and the first worldwide treatment for inherited blindness. Not only do they delve into the mechanics of the corrected gene injection, but they also explain what this milestone means for patient eligibility and how their marriage has played a role in the success of their research partnership.

    Dr. Jean Bennett is the F.M. Kirby Professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania, and Dr. Albert Maguire is a Professor of Ophthalmology at the Hospital of the University of Pennsylvania and Attending Physician in the Division of Pediatric Ophthalmology at Children’s Hospital of Philadelphia.


Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.